Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine

Front Pharmacol. 2018 Apr 3:9:293. doi: 10.3389/fphar.2018.00293. eCollection 2018.

Murilo S de Abreu^{1

2

3}, Ashton J Friend^{3

4}, Tamara G Amstislavskaya⁵, Allan V Kalueff^{6

7

8

9

10

11

12}

¹ Bioscience Institute, University of Passo Fundo, Passo Fundo, Brazil.
² Postgraduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria, Brazil.
³ Neuroscience Program, School of Science and Engineering, Tulane University, New Orleans, LA, United States.
⁴ The International Zebrafish Neuroscience Research Consortium, Slidell, LA, United States.
⁵ Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia.
⁶ School of Pharmacy, Southwest University, Chongqing, China.
⁷ Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.
⁸ Institute of Experimental Medicine, Almazov National Medical Research Center, St. Petersburg, Russia.
⁹ Ural Federal University, Ekaterinburg, Russia.
¹⁰ Russian National Granov's Research Center for Radiology and Surgical Technologies, Pesochny, Russia.
¹¹ Laboratory of Translational Biopsychiatry, Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia.
¹² ZENEREI Research Center, Slidell, LA, United States.

No abstract available

Keywords: Zebrafish; animal models; anxiety; hallucinogens; scopolamine.

Publication types